Physician profile
Jonathon Vigil
NPI 1326397829
$1,978.50
in general payments reported to CMS, 2019-2025
26 companies · $1,098 in 2025
The $1,098 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.19 · 2022: $214 · 2023: $233 · 2024: $361 · 2025: $1,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.47 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.91 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $219.13 | 2025 | Airsupra, Breztri |
| Pfizer INC. | $185.54 | 2021-2025 | |
| Indivior INC. | $138.20 | 2022-2025 | Sublocade |
| Lilly USA, LLC | $134.84 | 2023-2025 | Mounjaro, Zepbound, Kisunla |
| Novartis Pharmaceuticals Corporation | $130.86 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.75 | 2022-2024 | Caplyta |
| Novo Nordisk INC | $103.50 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $96.50 | 2024-2025 | Repatha, Otezla, Krystexxa |
| Exact Sciences Corporation | $95.48 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $91.88 | 2024-2025 | Shingrix, Arexvy, Bexsero |
| Braeburn INC. | $68.98 | 2023-2024 | Brixadi |
| Aimmune Therapeutics, INC. | $45.54 | 2024-2025 | Zenpep |
| Bioventus LLC | $45.44 | 2025 | Xcell |
| Merck Sharp & Dohme LLC | $32.26 | 2024-2025 | Capvaxive, Gardasil 9, Varivax |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $27.84 | 2025 | |
| Sunovion Pharmaceuticals INC. | $25.36 | 2021 | |
| Axsome Therapeutics, INC. | $21.18 | 2025 | Auvelity |
| Hologic Sales and Service, LLC | $20.77 | 2025 | Thinprep 2000 Processor, Aptima |
| Merz North America, INC. | $19.16 | 2022 | |
| Si-Bone, INC. | $18.13 | 2025 | |
| Cranial Technologies, INC | $17.67 | 2025 | Doc Band |
| Alkermes, INC. | $15.87 | 2023 | Vivitrol |
| Sonex Health, INC. | $14.26 | 2025 | Sx-One Microknife |
| Fidia Pharma USA INC. | $14.25 | 2025 | Hymovis, Triluron |
| Vertex Pharmaceuticals Incorporated | $14.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Vigil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.